Japan’s health ministry statistics from 2019 indicate that 37.5 per cent of men and 40.6 per cent of women get less than six hours of sleep a night on average. A Japanese businessman has a nap on backs of chairs during a preview of the Tokyo Motor Show in Makuhari, suburban Tokyo. Photo: AFP A … Read more
Viagra could do more than just boost men’s performance as a new study found that it might also slash the risk of Alzheimer’s disease by an impressive 50 percent. The key ingredient in Viagra, sildenafil, is also used in Revatio, a medicine for high blood pressure in the lungs. The research, published in the Journal … Read more
Alzheimer’s disease is the most common type of dementia in the UK. It is a progressive condition associated with the ongoing decline of the brain. This means symptoms typically get worse over time. They can include issues with memory and language, personality and behavioural changes and even difficulties with mobility. While we are more likely … Read more
The Biogen headquarters in Cambridge, Massachusetts, on Oct. 24, 2023. Vanessa Leroy | Bloomberg | Getty Images Biogen on Wednesday said it will discontinue the sale and development of its older and highly controversial Alzheimer’s drug Aduhelm to refocus the company’s efforts to treat the memory-robbing disease. The biotech company will focus on rolling out … Read more
Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple years ago. The drugmaker said Wednesday that it will end a study of the drug needed for full approval from the Food and Drug Administration, and it will stop sales of … Read more
Health Canada has green lit a drug previously approved for schizophrenia and depression to treat symptoms of agitation in Alzheimer’s patients. Rexulti (brexpiprazole) oral tablets manufactured by Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. were issued a Notice of Compliance by the regulator, according to a company release Wednesday. This approval was given after … Read more
In May 2021, Heather Sosa, a Vancouver resident, received distressing news from her husband’s medical professionals — they diagnosed him with a mental illness and admitted him to a hospital out of fear for his safety. But as time unfolded, it became apparent that the initial diagnosis was incorrect. Contrary to the earlier assessment, Heather’s … Read more
NEW YORK — Drugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that has developed a new antipsychotic, in a $14 billion deal. Bristol Myers Squibb and Karuna announced their merger agreement on Friday. The transaction, which amounts to $330 per share in cash, offers a premium of 53% over Karuna’s stock on … Read more
